InteGen is a diagnostic reagent manufacturing company that has developed disruptive technologies including innovative DNA probes with clinical applications in cancer genetics, miscarriages, prenatal diagnoses, and IVF. Using non-invasive liquid biopsy (2-3 cc peripheral blood) sample, all human cancers can be detected in 2 hours or less. Same test (OncoSure TM ) can monitor cancer treatment efficacy with 100% concordance with Clinical remission. OncoSure is also a very powerful screening test which can detect cancers at a much early stage than current expensive invasive and non-invasive serum marker and imaging tests like PSA, CT, and PET scan.

All probes are manufactured in our Orlando facility which is FDA compliant with quality system 21CFR820 and cGMP.

Our FDA registration number is #3011310310

Mission Statement
To develop and provide innovative reagents for the cytogenetics community that can profile individual chromosomes in interphase nuclei which produce results that are faster, more sensitive, failure-proof and cost-effective.

Vision
We envision improved patient care as the cytogenetics community employs interphase chromosome profiling technology and related products in their clinical practice. We further envision that with ICP in their tool box, cytogeneticists will never again sign a failed report and the international community will erase the words “marker”